IOVA · Iovance Biotherapeutics, Inc.
Market Cap
$3.75B
Shares
452.97M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-06 | Iovance Biotherapeutics Second Quarter 2026 Financial Results | Event |
| 2026-08-06 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-07 | Iovance Biotherapeutics First Quarter 2026 Financial Results | Event |
| 2026-05-07 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-11 | Barclays 28th Annual Global Healthcare Conference | Conference |
| 2026-03-02 | TD Cowen 46th Annual Healthcare Conference | Conference |
| 2026-02-24 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-24 | Fourth quarter and Full-year 2025 Financial Results and Corporate Updates | Event |
| 2025-11-06 | Iovance Biotherapeutics Third Quarter 2025 Financial Results | Event |
| 2025-09-09 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-09-05 | 2025 Wells Fargo Healthcare Conference | Conference |
| 2025-08-07 | Iovance Biotherapeutics Second Quarter 2025 Financial Results | Event |
Source: https://ir.iovance.com/
Key facts
CIK
1425205
CUSIP
462260100
13F (30d)
231 filings
229 filers
Visit website
Investor relations